Blackboard
   Expand   Collapse                             Search

Show details for 20142014
Hide details for 20152015
Show details for 0101
Show details for 0202
Show details for 0303
Show details for 0404
Show details for 0505
Show details for 0606
Show details for 0707
Show details for 0808
Show details for 0909
Show details for 1010
Hide details for 1111
11/30/201510:00 AMMiraval® Cosmic Bronze – The Second Effect Pigment in the New Product Series from Merck KGaA, Darmstadt, GermanyPR_PIGM_20151130_EMD.pdf
11/26/201507:00 AMGray Modules: New Dimension in Organic Photovoltaics for BuildingsMerck_GrayOPV_Chicago1.jpg Merck_GrayOPV_Chicago2.jpg Merck_OPV_Gray_20151126_EMD.pdf
11/25/201510:00 AMMerck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal ProductsLucianoRossetti.jpg MaceRothenberg_Pfizer.jpg OrphanUS.pdf
11/20/201508:00 AMMerck KGaA, Darmstadt, Germany, Counts on Africa for GrowthOschmannKley-Kenya15Nov16.jpg KLEY.JPG OSCHMANN.JPG MerckinAfrica_USI.pdf
11/18/201501:00 PMMerck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell CarcinomaAvelumab_BTD_18112015_US.pdf Home-Carousel-Main-1.jpg
11/18/201502:00 PMMerck KGaA, Darmstadt, Germany, Completes Sigma-Aldrich AcquisitionClosing_18112015_US.pdf Mercrobe_man_v1.jpg
11/12/201507:00 AMMerck KGaA, Darmstadt, Germany, Reports Jump in Earnings in Q3 2015Kley.jpg Q3_2015_PM_US.pdf
11/10/201505:25 PMMerck KGaA, Darmstadt, Germany, Set to Complete Sigma-Aldrich AcquisitionMercrobe_man_v1.jpg EU-Approval_10112015_US.pdf
11/06/201512:20 PMMerck KGaA, Darmstadt, Germany, Recognized for Digital Workplace PlatformEVA_Awards_Usa.pdf
11/06/201503:00 PMMerck KGaA, Darmstadt, Germany, Underscores Commitment to Equal OpportunityPM_Equal_Opportunity_US.pdf
11/05/201506:45 PMKarl-Ludwig Kley Joins Verizon Board of Directors11116HIGH_KLEY.JPG 05112015_Kley_Verizon_v4_US.pdf
11/04/201502:00 PMMerck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung CancerLucianoRossetti.jpg MaceRothenberg_Pfizer.jpg AvelumabNSCLCFirstLine_US.pdf
11/04/201508:00 PMMerck KGaA, Darmstadt, Germany, Hosts Hall of Fame of German Research for the First Timegerhard_ertl_mm_copyright_Dashuber.jpg manfred_weck_mm_copyright_Dashuber.jpg Hall_of_Fame_US.pdf
11/02/201502:00 PMExperts to Explore new Smart Materials at “Displaying Futures” SymposiumMerck_DisplayingFutures_20151102_EMD.pdf
Show details for 1212
Show details for 20162016
Show details for 20172017


   Expand   Collapse                             Search

© Merck KGaA, Darmstadt, Germany